POSA108 A Budget Impact Analysis of Atezolizumab Monotherapy for First Line Treatment of Patients with PD-L1 High Metastatic NSCLC in Italy
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.252
https://www.valueinhealthjournal.com/article/S1098-3015(21)02047-7/fulltext
Title :
POSA108 A Budget Impact Analysis of Atezolizumab Monotherapy for First Line Treatment of Patients with PD-L1 High Metastatic NSCLC in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02047-7&doi=10.1016/j.jval.2021.11.252
First page :
Section Title :
Open access? :
No
Section Order :
11025